Previous close | 32.28 |
Open | 32.16 |
Bid | 32.00 x 800 |
Ask | 32.53 x 800 |
Day's range | 31.93 - 32.45 |
52-week range | 27.25 - 48.25 |
Volume | |
Avg. volume | 1,284,749 |
Market cap | 2.698B |
Beta (5Y monthly) | 2.12 |
PE ratio (TTM) | 15.58 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to announce the Health Canada license of the Forma-I to address the symptoms of dry eye disease due to Meibomian gland dysfunction (MGD). Forma-I is intended for use in the periorbital area and eyelids and relieves inflammation of meibomian glands and eye irritation.